Results 31 to 40 of about 96,798 (264)

Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis.
Camilla H. B. Jespersen, Johanna Krøll, Priya Bhardwaj, Carl Johann Hansen, Jesper Svane, Bo G. Winkel, Christian Jøns, Peter Karl Jacobsen, Jens Haarbo, Jens Cosedis Nielsen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp‐Pedersen, Lars Køber, Jacob Tfelt‐Hansen, Peter E. Weeke   +16 more
doaj   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation [PDF]

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Syeda Emaan Gilani, Sundas Adnan Butt
openalex   +2 more sources

Risk Stratification in Post-MI Patients Based on Left Ventricular Ejection Fraction and Heart-Rate Turbulence [PDF]

, 2003
Objectives: Development of risk stratification criteria for predicting mortality in post-infarction patients taking into account LVEF and heart-rate turbulence (HRT).
Rolnitzky, Linda, Malik, M., Barthel, Petra, Schneider, Raphael, Schmidt, Georg, Bigger Jr., J. Thomas, Ulm, Kurt, Malik, Marek   +7 more
core   +1 more source

New horizon for infection prevention technology and implantable device

Journal of Arrhythmia, 2016
There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades.
Yusuke Kondo, MD, PhD, Marehiko Ueda, MD, PhD, Yoshio Kobayashi, MD, PhD, Joerg O. Schwab, MD, PhD   +3 more
doaj   +1 more source

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiac sympathetic denervation (CSD) has been used as a bailout strategy for refractory ventricular tachycardia (VT). Risk of VT recurrence in patients with scar‐related monomorphic VT referred for CSD and the extent to which CSD can modify ...
Veronica Dusi, Jeffrey Gornbein, Duc H. Do, Julie M. Sorg, Houman Khakpour, Yuliya Krokhaleva, Olujimi A. Ajijola, Carlos Macias, Jason S. Bradfield, Eric Buch, Osamu A. Fujimura, Noel G. Boyle, Jane Yanagawa, Jay M. Lee, Kalyanam Shivkumar, Marmar Vaseghi   +15 more
doaj   +1 more source

The death of cost-minimization analysis? [PDF]

, 2001
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Bernie J. O'Brien, Andrew H. Briggs, O'Brien, B.J., Briggs, A.H.   +3 more
core   +1 more source

Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis

Brazilian Journal of Cardiovascular Surgery
Objective: Implantable cardioverter-defibrillator has become the first-line therapy for prevention of sudden cardiac death. Controversial results still exist regarding the effectiveness of implantable cardioverter-defibrillator (ICD) in non-ischemic ...
Zhenhua Xing, Liang Tang, Chenyang Chen, Jiabing Huang, Zhaowei Zhu, Xinqun Hu   +5 more
doaj   +1 more source

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Short QT syndrome (SQTS) is a rare inheritable disease associated with sudden cardiac death. Data on long‐term outcomes of families with SQTS are limited.
Ibrahim El‐Battrawy, Johanna Besler, Volker Liebe, Rainer Schimpf, Erol Tülümen, Boris Rudic, Siegfried Lang, Christian Wolpert, Xiaobo Zhou, Ibrahim Akin, Martin Borggrefe   +10 more
doaj   +1 more source

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Myocardial bridge (MB), common anatomic variant, is generally considered benign, while previous studies have shown associations between MB and various cardiovascular pathologies.
Kozo Okada, Kiyoshi Hibi, Yutaka Ogino, Nobuhiko Maejima, Shinnosuke Kikuchi, Hidekuni Kirigaya, Jin Kirigaya, Ryosuke Sato, Hidefumi Nakahashi, Yugo Minamimoto, Yuichiro Kimura, Eiichi Akiyama, Yasushi Matsuzawa, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kouichi Tamura, Kazuo Kimura   +17 more
doaj   +1 more source

Patient‐Reported Outcomes in a Multidisciplinary Electrophysiology‐Psychology Ventricular Arrhythmia Clinic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Ventricular arrhythmias (VAs) and their treatment have been associated with psychological distress and diminished quality of life (QOL).
Uday Sandhu, Andrew T. Nguyen, John Dornblaser, Andrew Gray, Karen Paladino, Charles A Henrikson, Adrienne H. Kovacs, Babak Nazer   +7 more
doaj   +1 more source